ACCREDITATION AND CREDITS

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

EXCEL Continuing Education designates this educational activity for a maximum of 3.5 AMA PRA
Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

EXCEL Continuing Education is accredited by the FL Board of Nursing Provider # 50-619 and designates this activity for 3.5 contact hours. Physician Assistants accept AMA Category 1 Credit.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, the participants should be able to:

• Explain the basis for risk of stroke in patients with atrial fibrillation (AF).

• Discuss the efficacy of antiarrhythmic and antithrombotic therapy to reduce this risk.

• Implement guideline and evidence-based approaches for stroke prevention in AF for patients
in whom anticoagulant therapy is indicated and for those in whom it is contraindicated.

• Describe the impact of suboptimal antithrombotic prescribing practices and that of patients’ low
adherence to medications and initiate strategies to improve clinical outcomes.

• Summarize the role of platelet in thrombosis and latest data regarding antiplatelet therapy for AF
related stroke prevention.

TARGET AUDIENCE / PROGRAM OVERVIEW / NEEDS ASSESSEMENT

This activity has been designed to meet the educational needs of practicing clinicians, and is targeted
to cardiologists, electrophysiologists, internists, PCs and allied HCPs who treat patients for CV disease
and who must maintain a current understanding of cardiac arrhythmias, its various manifestations, and
available and emerging treatment options for stroke prevention in patients with AF.

The goal of this conference is two-fold: first, to highlight the under-recognized risk of stroke and/or inadequate prophylaxis in patients with AF and the associated morbidity, mortality, and cost burdens;
and second, to educate CV physicians and allied HCPs by providing a comprehensive review of the
most current evidence-based therapeutic strategies for the prevention of stroke in patients with AF.

SUPPORTER